Court sides with DuPont on case vs Novozymes

On June 27, 2019, the Danish Maritime and Commercial Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643). The court reasoned that Novozymes’ legal argument that an entitlement action could be based on prior art was without merit and awarded costs to Danisco.

“Testimony from the trial clearly showed that the inventions claimed in these patent applications were based on Danisco technology and reflect our long history of innovation throughout the globe,” said Wayne Ashton, Global Business Director for home and personal care at DuPont.